ORIGINAL RESEARCH article

Front. Public Health

Sec. Health Economics

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1588806

This article is part of the Research TopicIntegrating Economics into Population Health: Assessing Policies and OutcomesView all 3 articles

The effect of overuse by primary healthcare institutions on medical expenses: an empirical study from the Western regions of China

Provisionally accepted
垚  张垚 张1,2Yingqi  LiuYingqi Liu3Zhongliang  ZhouZhongliang Zhou3*Shaoqing  GongShaoqing Gong4*
  • 1Air Force Medical University, Xi'an, China
  • 2The Fourth Military Medical University, Xi'an, China
  • 3Xi'an Jiaotong University, Xi'an, China
  • 4Luohe Medical College, Luohe, China

The final, formatted version of the article will be published soon.

Background: Overuse stands as an important factor in the unreasonable growth of healthcare expenditure in many countries, increasing the burden of both patients and national healthcare insurance. The heterogeneity of diseases results in significant differences in clinical manifestations and treatment sensitivity among different patients with the same illness, making it urgently necessary to explore and resolve the objective assessment and measurement of overuse. This study aims to investigate the current status of overuse in primary healthcare services in China, analyze and discuss the effect of overuse on medical expenses, and draw attention to the issue of overuse. Results:(1) Among the 242 visits, overtreatment occurred 139 times, accounting for 57.44% of the total visits. Among them, over-examination accounted for 37.41%, and over-medication accounted for 62.58%. (2) Regarding medical expenditure, the average total medical cost per capita for the valid visits was 32.73 yuan, with examination fees amounting to 22.96 yuan and drug costs totaling 13.60 yuan. (3) Compared to the non-overuse group, patients in the overuse group incurred a total cost of 106.57 yuan, which was 54.33 yuan higher. The examination fees for the overuse group were 69.74 yuan, representing an additional expenditure of 18.83 yuan compared to the non-overuse patients. Drug costs for the overuse group were 39.27 yuan, an increase of 35.74 yuan compared to the non-overuse patients. Thus, overuse led to an increase of 104%, 27%, and 91% in total medical costs, examination fees, and drug costs, respectively. (4) For every additional unnecessary medical service item, the total medical cost will increase by 18.66 yuan, the examination cost will increase by 3.65 yuan, and the drug cost will increase by 14.48 yuan, with an increase rate of 13%, 17%, and 20%, respectively. For every additional unnecessary medical examination, the examination cost will increase by 11.28 yuan, with an increase rate of 13%, while there is no significant impact on total medical costs and drug costs. For every additional unnecessary drug item, the total medical cost will increase by 19.71 yuan, and the drug cost will increase by 9.81 yuan, with an increase rate of 29% and 27%.

Keywords: overuse, Medical expenses, unannounced standardized patient, Primary healthcare services, Western regions of china

Received: 06 Mar 2025; Accepted: 10 Apr 2025.

Copyright: © 2025 张, Liu, Zhou and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zhongliang Zhou, Xi'an Jiaotong University, Xi'an, 710049, China
Shaoqing Gong, Luohe Medical College, Luohe, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.